HYDROXOCOBALAMIN Injectable-30 mL MDV — Class II drug recall D-0719-2018
Terminated recall by Coastal Meds, LLC., reported 2018-05-02, distributed nationwide. Presence of Particulate matter. Recall due to presence of unknown particulate matter.
| Recall number | D-0719-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Coastal Meds, LLC., Biloxi, MS, United States |
| Recall initiated | 2018-04-05 |
| Classified | 2018-05-09 |
| Reported by FDA | 2018-05-02 |
| Terminated | 2020-11-24 |
| Distributed | Nationwide (US) |
| Quantity | 1,506 vials |
| Reason classes | specification failure |
| Lot numbers | CAH/101617 |
Product
HYDROXOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
Reason for recall
Presence of Particulate matter. Recall due to presence of unknown particulate matter.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0719-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.